Integral Health Asset Management
Integral Health Asset Management reported 96 stocks worth $1.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.0%), INSM (7.9%) and EWTX (6.0%). Compared with Q2 2026, the fund opened new positions in AMGN, INCY and ONC, added to EWTX, MRK and SRRK, trimmed RVMD, AXSM and VERA and sold out of ALHC, ABT and UNH.
Latest filing: what Integral Health Asset Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() RVMD Revolution Medicines Inc | $130M | 8.0% | 1M | −500K (−33%) | 8 of 8 | |
| 2 | ![]() INSM Insmed Inc | $129M | 7.9% | 1.6M | No change | 8 of 8 | |
| 3 | ![]() EWTX Edgewise Therapeutics Inc | $97.4M | 6.0% | 2.4M | +400K (+20%) | 8 of 8 | |
| 4 | ![]() CYTK Cytokinetics Inc | $72.5M | 4.5% | 1.6M | No change | 8 of 8 | |
| 5 | ![]() MRK Merck & Co Inc | $65.4M | 4.0% | 450K | +100K (+29%) | 5 of 8 | |
| 6 | ![]() SRRK Scholar Rock Hldg Corp | $60.6M | 3.7% | 1.3M | +505K (+67%) | 8 of 8 | |
| 7 | ![]() CNC Centene Corp Del | $46.6M | 2.9% | 750K | +450K (+150%) | 6 of 8 | |
| 8 | ![]() AXSM Axsome Therapeutics Inc | $46.1M | 2.8% | 250K | −50K (−17%) | 3 of 8 | |
| 9 | ![]() VERA Vera Therapeutics Inc | $32.3M | 2.0% | 1.5M | −250K (−14%) | 8 of 8 | |
| 10 | ![]() AMGN Amgen Inc | $31.6M | 1.9% | 75K | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() ALHC Alignment Healthcare Inc | $47.6M | 2M |
![]() ABT Abbott Labs | $36.3M | 400K |
![]() UNH Unitedhealth Group Inc | $35.3M | 85K |
![]() NVO Novo-Nordisk A S F | $28.8M | 600K |
![]() LNTH Lantheus Hldgs Inc | $21.1M | 190K |
🔒 Free account: see all 30.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
![]() EWTX Edgewise Therapeutics Inc | Call | $12.2M | 300K | +300,000 |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Integral Health Asset Management 13F FAQ
What does Integral Health Asset Management own?
Integral Health Asset Management reported 96 stocks worth $1.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.0%), INSM (7.9%) and EWTX (6.0%). The table above lists every position in the filing (the top 10 without an account).
What did Integral Health Asset Management buy and sell in Q3 2026?
Compared with Q2 2026: 39 new positions, 12 added to, 26 trimmed and 32 sold out. New positions include AMGN, INCY and ONC. It sold all of ALHC, ABT and UNH.
When will Integral Health Asset Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Integral Health Asset Management's portfolio worth?
The Q3 2026 filing reports $1.6B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























